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ABSTRACT 
Background: Regular exercise and diet may contribute to white adipose tissue 
(WAT) conversion into brown adipose-like phenotype that may increase resting 
energy expenditure (REE) leading to weight loss. We examined the relationship 
between REE, physical activity (PA) participation and diet with browning formation 
markers of subcutaneous WAT in healthy men. Materials and methods: We 
assessed REE, diet and body composition of 32 healthy men [age (years): 
36.06±7.36, body mass index (BMI): 27.06±4.62 (kg/m2)]. Participants also 
underwent measurements of PA (MET/minute/week) using the International Physical 
Activity Questionnaire, while they undertook a subcutaneous fat biopsy from the 
abdominal region to assess the mRNA of uncoupling protein 1 (UCP1), peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), peroxisome 
proliferator-activated receptor alpha (PPARα), and peroxisome proliferator-activated 
receptor gamma (PPARγ). Results: We found no associations between UCP1, 
PGC-1α, PPARα and PPARγ mRNAs with REE, PA levels and diet (p>0.05). 
However, PGC-1α, PPARα and PPARγ mRNAs were more expressed in individuals 
displaying moderate than low PA levels (p<0.05). Furthermore, PGC-1α, PPARα and 
PPARγ mRNAs were negatively correlated with fat mass percentage (p<0.05). PGC-
1α and PPARα mRNAs were also negatively correlated with BMI, while PGC-1α 
mRNA was inversely associated with waist-to-hip ratio (p<0.05). Conclusions: REE, 
PA levels and diet are not associated with browning formation indices of 
subcutaneous adipose tissue in healthy adult men.  
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LIST OF NON-STANDARD ABBREVIATIONS 
BAT: Brown adipose tissue 
BMI: Body mass index  
FNDC5: Fibronectin type III domain-containing protein 5  
IPAQ: International Physical Activity Questionnaire  
MET: Metabolic equivalent   
PA: Physical activity   
PGC-1α: Peroxisome proliferator-activated receptor gamma coactivator 1-alpha   
PPARα: Peroxisome proliferator activated receptor alpha  
PPARγ: Peroxisome proliferator activated receptor gamma  
REE: Resting energy expenditure  
UCP1: Uncoupling protein 1  
WAT: White adipose tissue  
WHR: Waist-to-hip ratio   
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Introduction 
Brown adipose tissue (BAT) in humans is characterized by increased mitochondrial 
content and an increased ability to uncouple cellular respiration via the action of 
uncoupling protein 1 (UCP1) in response to cold exposure [1]. This mechanism 
appears to be important, since UCP1-mediated thermogenesis may represent up to 
30% of resting energy expenditure (REE) in adult humans [2]. Animal studies have 
shown that increased BAT activity reduces weight gain, improves insulin sensitivity, 
lowers free fatty acid levels in serum, and reduces the risk for type 2 diabetes and 
other metabolic disorders [3-7]. Interestingly, some studies show that regular 
exercise training may increase BAT activity in animals [8-12], while evidence in 
humans suggests that participation in habitual physical activity (PA) is associated 
with BAT activity in supraclavicular and spinal areas [13]. Finally, a low protein diet 
[14, 15] and high-fat diet [16-19] in animals, may increase BAT activity due to diet-
induced thermogenesis that occurs via UCP1 activity [20]. 
White adipocytes also express UCP1, which indicates a brown adipose-like 
phenotype that may be been linked to obesity resistance in animals [3, 5, 21]. 
Several animal studies have also shown that exercise may initiate the conversion of 
subcutaneous white adipose tissue (WAT) into brown adipose-like phenotype 
indicated by the presence of UCP1 and several other genes [22-25]. For instance, 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), 
which is expressed in WAT [26], and peroxisome proliferator activated receptor 
gamma (PPARγ), can stimulate genes that are involved in the differentiation of 
brown fat cells [27, 28]. Furthermore, in vitro studies reported that PPARγ enhances 
UCP1 mRNA in both BAT [29] and WAT [30]. 
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It was also hypothesized that a physical exercise mechanism can increase 
REE leading to body weight loss, through the induction of a brown adipose-like 
phenotype in WAT [31]. More specifically, PGC-1α upregulates the production of the 
fibronectin type III domain-containing protein 5 (FNDC5) in skeletal muscle [31]. 
FNDC5 is then cleaved and releases into the bloodstream a product called Irisin [31]. 
Irisin may bind to the surface of white adipocytes changing their phenotype into 
brown-like adipocytes [31]. This hypothesis was confirmed by the presence of UCP1 
within WAT that may occur, at least in part, by the action of peroxisome proliferator 
activated receptor alpha (PPARα) [31], a transcription factor having a key role in the 
browning process of animal WAT [32]. Furthermore, regular exercise training 
increases PPARγ mRNA in WAT of mice [33, 34]. However, evidence in humans 
showed that regular exercise has no effect on UCP1 mRNA in WAT [35]. Given that 
humans display white adipocytes that may contain UCP1 [36] – the only known 
contributor to initiate BAT activity [1] – the presence of UCP1 in WAT cells indicates 
a brown adipose-like phenotype [37].  
Nutrition may also play role in the presence of UCP1 in WAT. For instance, a 
ketogenic diet (high-fat, adequate-protein and low-carbohydrate) may increase 
UCP1 expression in epididymal WAT of mice independently of PA levels [38]. 
Overall, the actual in vitro and in vivo evidence is inadequate or incomplete to 
support the browning formation of WAT in response to regular exercise and nutrition. 
Regarding exercise, this is mainly due to different types of animals and different 
exercise interventions used, while relevant data from human studies are very limited. 
Similarly, evidence from human studies to examine the effects of diet on browning 
formation of WAT barely exists. Therefore, the aim of the current study was to 
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examine the relationship between REE, PA participation and diet with browning 
formation markers of subcutaneous WAT in healthy men.  
 
Materials and methods 
 
Participants and procedure 
The study conformed to the standards set by the Declaration of Helsinki and was 
approved by the Ethics Committee of the University of Thessaly (protocol no. 
698/2013). The inclusion criteria were: healthy adult men, non-smokers, no chronic 
disease and/or being under medication treatment. Thirty-two healthy men [age 
(years): 36.06±7.36, body mass index (BMI): 27.06±4.62 (kg/m2)] were recruited by 
advertisements in a local newspaper in Trikala, Thessaly, Greece and the data 
collection started in July 2013 and ended in June 2014. The characteristics of the 
participants are shown in Table 1. 
To assess energy and nutrient intake of the participants, we retrieved diet 
recalls from two weekdays and one weekend day that were randomly selected within 
a week prior to the measurements. On the day of the measurements, the participants 
visited the laboratory between 07:00 and 09:00 am and completed the “usual week” 
short form of the International Physical Activity Questionnaire (IPAQ) that has been 
validated for healthy Greek adults [39]. Subsequently, participants underwent the 
following anthropometry measurements: body height was measured using a Seca 
(Hamburg, Germany) stadiometer, body weight was measured using a precision 
scale (KERN & Sohn GmbH, Version 5.3, Germany), while waist-to-hip ratio (WHR) 
was assessed using a tape measure. Percent body fat and fat-free mass were 
measured via bioelectrical impedance using a body composition monitor (Fresenius 
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Medical Care AG & Co. KGaA D-61346 Bad Hamburg, Germany). Finally, the 
participants underwent an assessment of REE by indirect calorimetry that was 
followed by a subcutaneous fat biopsy. 
 
Assessment of resting energy expenditure 
Participants were instructed to transport themselves to the research laboratory in a 
vehicle on the day of the measurement. REE assessments were conducted between 
07:00 to 09:00 am following a 12-hour fast, while participants refrained from 
exercise, alcohol, and passive smoking during the 72 hours prior to the 
measurements [40, 41]. REE was measured using an automated gas analyser 
(Vmax, CareFusion, USA) to record respiratory variables every 20 seconds in a 
supine position for 30 minutes within a quiet room maintained at 22-24°C. From the 
30 minutes of the collected data, the first and last five minutes were removed [41]. 
The remaining 20 minutes of the collected data were averaged to obtain the final 
REE (kcal) value [41]. Respiratory  gas  measurements  were  extracted using the 
Weir equation [42] to  convert VO2 and VCO2 values to REE (kcal) values. 
 
Assessment of physical activity (PA) levels 
IPAQ is self-reported and was completed by each participant at the laboratory. 
Detailed explanations were provided to the participants to ensure the clarity of the 
questionnaire while an investigator was continuously available for further 
clarification. The obtained data were transformed into weekly metabolic equivalent 
(MET-minute/week) based on low, moderate, and vigorous PA intensity, number of 
days/week and minutes/day of their PA participation following IPAQ guidelines [43]. 
More specifically, the following equations were used: a) Walking (Low level) = 3.3 
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MET*minutes of walking*days of activity, b) Moderate intensity level = 4 METs 
*minutes of walking*days of activity, and c) High (vigorous) intensity level = 8 
MET*minutes of walking*days of activity. The total MET-minute/week for each 
participant was calculated according to the equation: MET-minute/week = Walking 
(MET*min*days) + Moderate (MET*min*days) + High [(vigorous) (MET*min*days)] 
[43].  
The PA categories were grouped based on the number of days/week, 
minutes/day, and number of MET-minute/week of PA [43]. Specifically, the PA level 
of the participants that did not meet the criteria for “moderate” and/or “high” levels of 
PA was classified as “low”. The PA level of the participants who reported: a) three or 
more days of vigorous-intensity activity of at least 20 minutes/day, or b) five or more 
days of moderate-intensity activity and/or walking of at least 30 minutes/day, or c) 
five or more days of any combination of walking, moderate-intensity or vigorous-
intensity activities with a minimum total PA of at least 600 MET-minute/week, was 
classified as “moderate” [43]. Finally, the PA level of the participants who reported: 
a) vigorous-intensity activity on at least three days/week with a minimum total PA of 
at least 1500 MET-minute/week, or b) seven days/week of any combination of low, 
moderate, or vigorous intensity activities with a minimum total PA of at least 3000 
MET-minute/week was classified as “high” [43].  
 
Subcutaneous fat biopsies 
All biopsies were executed by an experienced surgeon following a previous 
methodology [44] based on a standardised non-diathermy method (Chachopoulos et. 
al. 2017, unpublished data). The participants underwent a subcutaneous fat biopsy 
after at least a 12-hour fast [45]. Each participant was positioned on a surgical bed in 
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a supine position. The site of the incision was disinfected and a 10 ml of 2% 
xylocaine (no adrenaline) was injected in the region of the incision for local 
anaesthesia. An incision was made until the adipose tissue was revealed that was 
approximately 3-5 cm to the left or right of the navel while the incision length was 
approximately 2-2.5 cm. Subsequently, the subcutaneous tissue was removed with 
operating scissors and when the adipose tissue became visible nearly 500 mg of 
adipose tissue was captured and removed. The collected adipose tissue sample was 
immediately immersed in liquid nitrogen at -190°C. For the final deposition, the 
samples were placed in Eppendorf tubes and they were deposited in a freezer at -
80°C until analysis. 
 
Gene expression analysis 
The analysis of gene expression has been done by an investigator who was blinded 
to the aim of the study. Total RNA was extracted from adipose tissue biopsies using 
RNeasy Lipid Tissue mini kit (QIAGEN) following the manufacturer’s protocol. First-
strand cDNAs were synthesized from equal amounts of total RNA using random 
primers and M-MLV reverse transcriptase (Promega). Quantitative real time 
polymerase chain reaction for the UCP1, PGC-1α, PPARα, and PPARγ genes was 
performed using Sybr Green fluorophore. The change in fluorescence at every cycle 
was monitored and a threshold cycle above background for each reaction was 
calculated. A melt curve analysis was performed following every run to ensure a 
single amplified product for every reaction. All reactions were carried out in at least 
duplicated for every sample. 18S rRNA gene was constantly expressed under all 




Assessment of diet  
The participants were contacted by telephone – at 22:00 pm, after their last meal –  
on three separate randomly-selected days (two weekdays, one weekend day) during 
a one-week period for the completion of a 3-day diet record. All food and beverages 
consumed on the day of contact were recorded. All diet records were analysed by a 
trained investigator using the software Nutritionist Pro, Version 5.4.0, Axxya Systems 
(Redmond, WA, USA). This software has been previously used for research 
purposes [47, 48]. For the analysis, a search was conducted in Nutritionist Pro for 
each food and beverage consumed. Details regarding the amount and preparation of 
each food and/or beverage were also included. Once all the relevant information 
regarding the food or beverage was entered the software, a corresponding list of 
macro and micronutrient content was provided and subsequently saved. This 
process was repeated for all food and beverages listed on the diet record. If a food 
or beverage was not found within the Nutritionist Pro database, the investigator 
manually entered the macro and micronutrient content of that food and saved it to 
the database for future use. The feedback provided by the software for each food or 
beverage used in this study included the total energy intake (kcal), total weight of 
food (gr), protein (gr), carbohydrate (gr), total fat (gr), sugar (gr) and caffeine (mg). 
 
Statistical analysis 
Following previous methodology, we removed the mean values (i.e. outliers) of 
UCP1, PGC-1α, PPARα and PPARγ mRNAs that were at a distance of more than 
two standard deviations from the mean of the distribution [13, 49]. This analysis 
resulted to the removal of two data points of PGC-1α, one of PPARα and two of 
 11 
PPARγ, while UCP1 values displayed no outliers. Non-parametric tests were used 
throughout. We examined associations between UCP1, PGC-1α, PPARα, and 
PPARγ mRNAs with REE, PA (MET-minute/week), energy intake (kcal), total weight 
of food (gr), protein (gr), carbohydrate (gr), total fat (gr), sugar (gr) and caffeine (mg) 
as well as age, BMI, WHR, fat mass percentage, fat free mass (kg), using Spearman 
correlation coefficient. We used Mann-Whitney U tests to assess differences of 
UCP1, PGC-1α, PPARα and PPARγ mRNAs due to variation in PA levels 
(low/moderate) and Kruskal-Wallis analysis of variance with post hoc Mann-Whitney 
U tests to assess differences of BMI categories (normal/overweight/obese). All 
analyses were conducted with SPSS (version 22; SPSS Inc., Chicago, IL, USA) and 
a p≤0.05 level of significance. 
 
Results 
We found no associations between the mRNAs of UCP1, PGC-1α, PPARα and 
PPARγ genes with REE and PA levels (p>0.05). Mann–Whitney U tests showed that 
PGC-1α (z=-2.468, p=0.01), PPARα (z=-2.093, p=0.04) and PPARγ (z=-1.998, 
p=0.05) mRNAs were more expressed in individuals displaying moderate than low 
PA levels (Figure 1), while the IPAQ data analysis revealed that none of the 
participants displayed high PA levels. Finally, we found no associations between 
UCP1, PGC-1α, PPARα and PPARγ mRNAs with age, energy intake (kcal), total 
weight of food (gr), protein (gr), carbohydrate (gr), total fat (gr), sugar (gr) and 
caffeine (mg).  
The PGC-1α mRNA was negatively correlated with fat mass percentage 
(rho=-0.69, p=0.001) (Figure 2A), BMI (rho=-0.78, p=0.001) (Figure 2B), and WHR 
(rho=-0.62, p=0.001) (Figure 2C). Similarly, the PPARα mRNA was negatively 
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associated with fat mass percentage (rho=-0.45, p=0.01) (Figure 3A) and BMI (rho=-
0.45, p=0.01) (Figure 3B), while the PPARγ mRNA was negatively correlated with 
BMI (rho=-0.40, p=0.03) (Figure 4). Additionally, individuals with normal BMI (19-
24.9 kg/cm2) revealed increased PGC-1α mRNA (z=-2.276, p=0.02) compared to 
overweight individuals (BMI 25-29.9 kg/m2) (Figure 5). Also, individuals with normal 
BMI revealed increased PGC-1α mRNA (z=-3.220, p=0.001), PPARα mRNA (z=-
1.987, p=0.05) and PPARγ mRNA (z=-2.167, p=0.03) compared to obese individuals 
(BMI ≥30 kg/m2) (Figure 5). Finally, overweight individuals (BMI=24.9-29.9 kg/cm2) 
revealed increased PGC-1α mRNA (z=-2.325, p=0.02) compared to obese 
individuals (BMI ≥30 kg/m2) (Figure 5). 
 
Discussion 
The aim of the current study was to examine the relationship between REE, PA 
participation and diet with browning formation markers of subcutaneous WAT in 
healthy men. We found no associations between UCP1, PGC-1α, PPARα and 
PPARγ mRNAs and REE. In contrast to previous evidence showing that UCP1 in 
WAT was positively correlated with REE and negatively with BMI and weight loss 
[31], the current study could not confirm any link between UCP1 mRNA in WAT and 
metabolism indices (i.e. REE, BMI, WHR, fat mass and fat-free mass). Considering 
the recent finding that UCP1 mRNA in WAT is negatively associated with weight loss 
in healthy women [50] we could hypothesize the opposite; that is, increased REE 
and body weight loss could affect UCP1 in WAT. Nevertheless, this remains to be 
elucidated. Previous data also showed that PPARγ promotes brown adipose-like 
phenotype of WAT  [23, 30] and it would be expected to be positively associated with 
REE since increased REE may be the result of browning formation in WAT [51-53]. 
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However, the PPARγ activation in BAT may promote REE via fatty acid oxidation, 
although, this process may be suppressed in WAT because of the repression of 
PPARγ by the steroid receptor coactivator-2, which increases triglyceride 
accumulation and decreases free fatty acids in WAT [54]. This may explain, at least 
in part, the findings in the current study. 
 Based on a recent suggestion that regular exercise training may transform 
WAT cells into brown-like adipocytes [31, 55], we would expect to observe that 
individuals with increased PA levels would display increased UCP1 mRNA – the 
direct marker of browning formation of WAT [37]. However, we found no association 
between UCP1 mRNA and PA levels. This finding is in line with the only controlled 
trial published to date reporting a non-significant increase of UCP1 mRNA in 
subcutaneous WAT of healthy adults in response to a 12-week exercise training 
intervention [35]. Furthermore, a recent single group design study showed no 
change in the gene expression of browning markers (including UCP1) in WAT of 
healthy women after a 16-week exercise training intervention [50].   
As previously suggested, PGC-1α, PPARα and PPARγ mRNA can affect 
UCP1 to cause browning formation in WAT [30, 31, 56]. We found no associations 
between the mRNAs of PGC-1α, PPARα and PPARγ genes with PA levels. 
However, we observed that individuals with moderate PA levels express more PGC-
1α, PPARα, and PPARγ mRNAs than individuals with low PA levels. PGC-1α is 
increased in WAT in response to exercise in mice [23, 57]. In humans however, 
PGC-1α mRNA did not change after an 8-week resistance training intervention [58]. 
PPARα was suggested to increase UCP1 mRNA in WAT in response to exercise 
[31] while PPARγ of subcutaneous fat of mice was not altered in response to an 8-
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week exercise programme [59] or it was increased in response to chronic exercise in 
mice [33].  
Collectively, activation of PGC-1α, PPARα and PPARγ genes could indicate 
browning formation of WAT through the increase of UCP1 expression [31, 32, 60]. 
Nevertheless, even though we observed that PGC-1α, PPARα and PPARγ mRNAs 
are more expressed in individuals that display moderate than low PA levels, this was 
not accompanied by a relevant association with UCP1 mRNA. Also, we found no 
positive associations between PGC-1α, PPARα, and PPARγ mRNAs with REE. 
Increased REE may result from browning formation in WAT [51-53] while PA levels 
are positively associated with REE in humans [61]. Notably, we did not detect an 
association between PA levels and REE in the current study. Furthermore, we found 
that none of the genes examined in the current study are associated with the diet of 
our participants. In this regard, a previous animal study showed that a ketogenic diet 
(high-fat, adequate-protein and low-carbohydrate) could increase UCP1 in WAT [38]. 
Our participants did not follow a ketogenic diet, which may explain our findings.  
The inverse association of PGC-1α mRNA with fat mass, BMI and WHR, 
indicates low demand of energy in WAT given that PGC-1α increases fatty acid 
oxidation in mice [62, 63], which designates increased demands of energy. An 
inverse association between PPARα mRNA with fat mass and BMI, was also found. 
PPARα is activated under conditions of energy deprivation [64] and its activation 
promotes the catabolism of fatty acid beta oxidation [65]. Given that WAT is mainly 
responsible for energy storage [66], the inverse associations of PPARα mRNA with 
fat mass and BMI indicate increased energy storage in WAT. Furthermore, PPARγ 
mRNA was inversely associated with BMI in the current study. PPARγ increases 
fatty acids uptake in WAT via the improvement of insulin sensitivity [67], while it 
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increases glucose uptake in WAT [68]. Given that free fatty acids are positively 
correlated with increased adiposity in adults [69] the observed inverse association of 
PPARγ mRNA with BMI in the current study seems believable.    
It is reasonable to assume that the present results may have been influenced 
by methodological limitations such as the lack of prior power calculation to determine 
an appropriate sample size. However, this was not possible given the lack of similar 
design studies that could be utilised to perform sample size calculations. Therefore, 
a post-measurement power calculation was conducted using an online software 
(DSS Research) to test >95% statistical power. This revealed 100% of power based 
on the UCP1 mRNA value (0.27±0.15) we detected in our study and expected UCP1 
mRNA value (0.00010±0.0003) from a previous controlled trial that examined the 
effect of exercise on UCP1 mRNA of subcutaneous WAT in humans [35]. The study 
only measured mRNAs of the genes examined. The quantity of mRNA indicates the 
transcription levels of a specific gene which could be associated to protein 
concentrations. However, it is well known that protein concentrations cannot be 
predicted from mRNA levels [70-72] as one molecule of mRNA may be used several 
times to encode the same protein [70-72]. Therefore, an analysis of the protein 
concentrations should be performed in the future to assess whether these proteins 
are involved in the browning formation of WAT in humans.  
UCP1 mRNA is stimulated by thyroid hormones such as triiodothyronine [73]. 
Unfortunately, we were unable to measure thyroid hormones in our study to 
determine any potential relationship with UCP1 mRNA. Even though the thyroid 
hormones were not measured, our participants had no clinical symptoms or 
characteristics of overt hypothyroidism. Also, hypothyroidism is more common in 
women than in men (~7 fold) [74]. Given that our participants were only men, we are 
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confident that their thyroid status could not affect UCP1 mRNA. Additionally, it is 
important to note that our participants were not highly active, as we did not detect 
individuals with high PA levels. Furthermore, even though a 3-day diet recall is 
considered an optimal tool to assess diet [75], it may also underestimate the energy 
intake [76]. Finally, our findings are different from those in animal studies, which can 
be primarily explained by the different conditions that our participants were exposed 
compared to animals (i.e. PA levels, diet).  
 
CONCLUSIONS 
We conclude that REE, PA levels and diet are not associated with browning 
formation markers of subcutaneous adipose tissue in healthy men. This reflects the 
conditions that our participants were exposed regarding the PA levels and diet. 
UCP1 mRNA in WAT is not linked to body weight and composition (i.e. BMI, WHR, 
fat mass). PGC-1α, PPARα and PPARγ mRNAs are negatively associated with 
increased fat mass accumulation parameters (BMI, WHR and fat mass) suggesting a 
positive association of PGC-1α, PPARα and PPARγ with lipid catabolism in WAT. 
The mechanisms of the latter associations remain to be determined.  
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Table 1: Characteristics of the participants 
 Mean ± Standard deviation 
Age 36.06±7.36 
Waist to hip ratio 0.91±0.07 
Body mass index 27.60±4.62 
Fat mass % 28.32±8.57 
Fat-free mass (kg) 52.90±5.02 
MET/minute/week 914±736 
MET: Metabolic equivalent  
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FIGURES 
Figure 1: UCP1, PGC-1α, PPARα and PPARγ mRNA expressions of subcutaneous 
white adipocytes in healthy men due to variation of low and moderate physical 
activity levels  
 
*Significant differences between low and moderate levels of PGC-1α (p=0.01), 
PPARα (p=0.04) and PPARγ (p=0.05) mRNA expressions. UCP1: Uncoupling 
protein 1; PGC-1α: peroxisome proliferator-activated receptor gamma coactivator 1-
alpha; PPARα: peroxisome proliferator activated receptor alpha; PPARγ: peroxisome 




Figure 2: Associations of fat mass, body mass index and waist to hip ratio with 
PGC-1α mRNA expression of subcutaneous white adipocytes in healthy men  
 




Figure 3: Associations of fat mass and body mass index with PPARα mRNA 
expression of subcutaneous white adipocytes in healthy men 
 




Figure 4: Associations of body mass index with PPARγ mRNA of subcutaneous 
white adipocytes in healthy men 
 




Figure 5: UCP1, PGC-1α, PPARα and PPARγ mRNA expressions of subcutaneous 
white adipocytes in healthy men due to variation of body mass index 
 
*Significant differences between normal and overweight individuals of PGC-1α 
mRNA (p=0.02) 
# Significant differences between normal and obese individuals of PGC-1α mRNA 
(p=0.001), PPARα mRNA (p=0.05) and PPARγ mRNA (p=0.03). 
£ Significant differences between overweight and obese individuals of PGC-1α 
mRNA (p=0.02)  
UCP1: Uncoupling protein 1; PGC-1α: peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha; PPARα: peroxisome proliferator activated receptor 
alpha; PPARγ: peroxisome proliferator activated receptor gamma 
